Trial Profile
An international, multicenter prospective single arm study to investigate, procedural, clinical and angiographic outcomes using the Taxus Liberte stent, with improved side branch access, following the provisional side branch T-stenting approach, in patients with complex lesions
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 17 Sep 2011
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms LIBERTY-ONE
- 16 Sep 2011 Status changed from not yet recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 05 Feb 2007 New trial record.